Judy L Aschner1, Adam Anderson2, James Christopher Slaughter3, Michael Aschner4, Steven Steele5, Amy Beller5, Amanda Mouvery5, Heather M Furlong6, Nathalie L Maitre7. 1. Departments of Pediatrics, Center for Molecular Toxicology, and Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, TN; Departments of Pediatrics and Obstetrics and Gynecology and Woman's Health, Albert Einstein College of Medicine of Montefiore Health and The Children's Hospital at Montefiore, Bronx, NY; judy.aschner@einstein.yu.edu. 2. Vanderbilt Center for Imaging Sciences. 3. Biostatistics, and. 4. Center for Molecular Toxicology, and Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, TN; 5. Departments of Pediatrics. 6. Department of Pediatrics, Wake Forest Baptist Health, Winston-Salem, NC; and. 7. Departments of Pediatrics, Physical Medicine and Rehabilitation, Center for Molecular Toxicology, and Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, TN; Department of Pediatrics and the Research Institute at Nationwide Children's Hospital, Columbus, OH.
Abstract
BACKGROUND: Manganese, an essential metal for normal growth and development, is neurotoxic on excessive exposure. Standard trace element-supplemented neonatal parenteral nutrition (PN) has a high manganese content and bypasses normal gastrointestinal absorptive control mechanisms, which places infants at risk of manganese neurotoxicity. Magnetic resonance (MR) relaxometry demonstrating short T1 relaxation time (T1R) in the basal ganglia reflects excessive brain manganese accumulation. OBJECTIVE: This study tested the hypothesis that infants with greater parenteral manganese exposure have higher brain manganese accumulation, as measured by MR imaging, than do infants with lower parenteral manganese exposure. DESIGN: Infants exposed to parenteral manganese were enrolled in a prospective cohort study. Infants classified as having high manganese exposure received >75% of their nutrition in the preceding 4 wk as PN. All others were classified as having low exposure. Daily parenteral and enteral manganese intakes were calculated. Whole-blood manganese was measured by high-resolution inductively coupled plasma mass spectrometry. Brain MR relaxometry was interpreted by a masked reviewer. Linear regression models, adjusted for gestational age (GA) at birth, estimated the association of relaxometry indexes with total and parenteral manganese exposures. RESULTS: Seventy-three infants were enrolled. High-quality MR images were available for 58 infants, 39 with high and 19 with low manganese exposure. Four infants with a high exposure had blood manganese concentrations >30 μg/L. After controlling for GA, higher parenteral and total manganese intakes were associated with a lower T1R (P = 0.01) in the globus pallidus and putamen but were not associated with whole-blood manganese (range: 3.6-56.6 μg/L). Elevated conjugated bilirubin magnified the association between parenteral manganese and decreasing T1R. CONCLUSION: A short T1R for GA identifies infants at risk of increased brain manganese deposition associated with PN solutions commonly used to nourish critically ill infants. These trials were registered at clinicaltrials.gov as NCT00392977 and NCT00392730.
BACKGROUND:Manganese, an essential metal for normal growth and development, is neurotoxic on excessive exposure. Standard trace element-supplemented neonatal parenteral nutrition (PN) has a high manganese content and bypasses normal gastrointestinal absorptive control mechanisms, which places infants at risk of manganeseneurotoxicity. Magnetic resonance (MR) relaxometry demonstrating short T1 relaxation time (T1R) in the basal ganglia reflects excessive brain manganese accumulation. OBJECTIVE: This study tested the hypothesis that infants with greater parenteral manganese exposure have higher brain manganese accumulation, as measured by MR imaging, than do infants with lower parenteral manganese exposure. DESIGN:Infants exposed to parenteral manganese were enrolled in a prospective cohort study. Infants classified as having high manganese exposure received >75% of their nutrition in the preceding 4 wk as PN. All others were classified as having low exposure. Daily parenteral and enteral manganese intakes were calculated. Whole-blood manganese was measured by high-resolution inductively coupled plasma mass spectrometry. Brain MR relaxometry was interpreted by a masked reviewer. Linear regression models, adjusted for gestational age (GA) at birth, estimated the association of relaxometry indexes with total and parenteral manganese exposures. RESULTS: Seventy-three infants were enrolled. High-quality MR images were available for 58 infants, 39 with high and 19 with low manganese exposure. Four infants with a high exposure had blood manganese concentrations >30 μg/L. After controlling for GA, higher parenteral and total manganese intakes were associated with a lower T1R (P = 0.01) in the globus pallidus and putamen but were not associated with whole-blood manganese (range: 3.6-56.6 μg/L). Elevated conjugated bilirubin magnified the association between parenteral manganese and decreasing T1R. CONCLUSION: A short T1R for GA identifies infants at risk of increased brain manganese deposition associated with PN solutions commonly used to nourish critically ill infants. These trials were registered at clinicaltrials.gov as NCT00392977 and NCT00392730.
Authors: Brad A Racette; Michael Aschner; Tomas R Guilarte; Ulrike Dydak; Susan R Criswell; Wei Zheng Journal: Neurotoxicology Date: 2011-12-21 Impact factor: 4.294
Authors: J M Fell; A P Reynolds; N Meadows; K Khan; S G Long; G Quaghebeur; W J Taylor; P J Milla Journal: Lancet Date: 1996-05-04 Impact factor: 79.321
Authors: D B Bertinet; M Tinivella; F A Balzola; A de Francesco; O Davini; L Rizzo; P Massarenti; M A Leonardi; F Balzola Journal: JPEN J Parenter Enteral Nutr Date: 2000 Jul-Aug Impact factor: 4.016
Authors: Vanessa A Fitsanakis; Na Zhang; Joel G Anderson; Keith M Erikson; Malcolm J Avison; John C Gore; Michael Aschner Journal: Toxicol Sci Date: 2008-01-30 Impact factor: 4.849
Authors: Tao Ke; Marta Sidoryk-Wegrzynowicz; Edward Pajarillo; Asha Rizor; Félix Alexandre Antunes Soares; Eunsook Lee; Michael Aschner Journal: Neurochem Res Date: 2019-09-30 Impact factor: 3.996
Authors: Maria Camilla Rossi Espagnet; Luca Pasquini; Antonio Napolitano; Antonella Cacchione; Angela Mastronuzzi; Roberta Caruso; Paolo Tomà; Daniela Longo Journal: Pediatr Radiol Date: 2016-12-09
Authors: Tiara R Ahmad; Sei Higuchi; Enrico Bertaggia; Allison Hung; Niroshan Shanmugarajah; Nicole C Guilz; Jennifer R Gamarra; Rebecca A Haeusler Journal: J Biol Chem Date: 2020-07-20 Impact factor: 5.157
Authors: Rekha C Balachandran; Somshuvra Mukhopadhyay; Danielle McBride; Jennifer Veevers; Fiona E Harrison; Michael Aschner; Erin N Haynes; Aaron B Bowman Journal: J Biol Chem Date: 2020-03-18 Impact factor: 5.157
Authors: Kelly M Bakulski; Young Ah Seo; Ruby C Hickman; Daniel Brandt; Harita S Vadari; Howard Hu; Sung Kyun Park Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Melanie L Foster; Thomas B Bartnikas; Hailey C Maresca-Fichter; Courtney Mercadante; Miriam Dash; Chelsea Miller; David C Dorman Journal: Neurotoxicology Date: 2017-10-08 Impact factor: 4.294
Authors: Airton C Martins; Silvana Ruella Oliveira; Fernando Barbosa; Alexey A Tinkov; Anatoly V Skalny; Abel Santamaría; Eunsook Lee; Aaron B Bowman; Michael Aschner Journal: Expert Opin Drug Metab Toxicol Date: 2021-03-04 Impact factor: 4.481